Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Veregen® 10%:Mylan Pharma GmbH
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
D06BB12 - SinecatechinsATC-DDD Version 2016. Source: WHO
D - Dermatologicals

Most of the drugs in this group are preparations for topical use. Some few preparations for systemic use with clear dermatological applications, e.g. griseofulvin (antimycotic), retinoids (for treatment of acne) and psoralens and retinoids (for treatment of psoriasis) are classified in this group.

Only oral preparations in ATC group D are given DDDs. Most products in this group are for topical use, and no DDDs are assigned because the amount given per day can vary very much according to the intensity and distribution of the disease. Consumption figures for these dermatological preparations can be expressed in grams of preparations regardless of strength.

D06 - Antibiotics and Chemotherapeutics for Dermatological Use

This group comprises products for topical use in skin infections etc.

D06B - Chemotherapeutics for Topical Use

This group includes chemotherapeutics for dermatological use, except:
Combinations with antibiotics - D06C
Combinations with corticosteroids - D07C

D06BB - Antivirals

This group includes both direct acting antivirals and other agents for viral diseases.
Mucoadhesive formulations of aciclovir are classified in J05AB01.
Podophyllin preparations are classified at the 5th level for podophyllotoxin.

D06BB12 - Sinecatechins
2020 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home